PPARGC1A and cancer: In addition, several studies showed that PGC-1α exhibits anti-fatigue activity in people with cancer-related fatigue and deficiency syndrome (Kim et al., 2020; Yang et al., 2022), which suggests an improvement in the mitochondrial function of skeletal muscle cells.